![Marc d'Abbadie](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marc d'Abbadie
Director/Board Member at
Spark Nw Carry Partner LLP
Profile
Dr. Marc d'Abbadie is an Investment Director at SPARK Impact Ltd. He is on the Board of Directors at Dadu Investments Ltd., Nwf4b Directors Ltd., Spark Nw Carry Partner LLP and Videregen Ltd.
Dr. d'Abbadie was previously employed as a Non-Executive Director by Evgen Pharma Plc, a Non-Executive Director by Evgen Ltd., a Non-Executive Director by Absynth Biologics Ltd., a Non-Executive Director by EnXray Ltd., a Consultant by McKinsey & Co., Inc., and a Non-Executive Director by Zilico Ltd.
He received his graduate degree from Trinity College, Cambridge and a doctorate degree from the University of Cambridge.
Marc d'Abbadie active positions
| Companies | Position | Start |
|---|---|---|
SPARK Impact Ltd.
 SPARK Impact Ltd. Investment ManagersFinance SPARK Impact invests in companies located in the United Kingdom. The firm targets companies operating in the fields of pharmaceuticals, biotechnology, diagnostics, clinical research, analytical services & sciences, healthcare technologies and medical devices. It provides financing for early and growth stage capital requirements. | Private Equity Investor | - |
Videregen Ltd.
 Videregen Ltd. BiotechnologyHealth Technology Operates a regenerative medicine company created to address the chronic shortage of organs for transplantation | Director/Board Member | - |
Spark Nw Carry Partner LLP | Director/Board Member | - |
Nwf4b Directors Ltd. | Director/Board Member | - |
Dadu Investments Ltd. | Director/Board Member | - |
Former positions of Marc d'Abbadie
| Companies | Position | End |
|---|---|---|
| THERACRYF PLC | Director/Board Member | 07/11/2018 |
EnXray Ltd.
 EnXray Ltd. Information Technology ServicesTechnology Services Develops sterilization technology solutions for medical device manufacturing companies | Director/Board Member | - |
Absynth Biologics Ltd.
 Absynth Biologics Ltd. BiotechnologyHealth Technology Develops and manufactures immunological prophylaxis, novel vaccines and therapies | Director/Board Member | - |
Zilico Ltd.
 Zilico Ltd. BiotechnologyHealth Technology Develops a medical device to detect cervical cancer and pre-cancerous cells in the cervix | Director/Board Member | - |
| ░░░░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Marc d'Abbadie
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
10
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Evgen Pharma Plc
 Evgen Pharma Plc Medical/Nursing ServicesHealth Services Engages in the development of pharmaceutical products and focus on cancer & neurological disease | Health Services |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trinity College, Cambridge
 Trinity College, Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Absynth Biologics Ltd.
Absynth Biologics Ltd. BiotechnologyHealth Technology Develops and manufactures immunological prophylaxis, novel vaccines and therapies | Health Technology |
Zilico Ltd.
Zilico Ltd. BiotechnologyHealth Technology Develops a medical device to detect cervical cancer and pre-cancerous cells in the cervix | Health Technology |
Evgen Ltd.
 Evgen Ltd. Medical/Nursing ServicesHealth Services Develops novel glucosinolate based products for the prevention and treatment of human disease | Health Services |
SPARK Impact Ltd.
SPARK Impact Ltd. Investment ManagersFinance SPARK Impact invests in companies located in the United Kingdom. The firm targets companies operating in the fields of pharmaceuticals, biotechnology, diagnostics, clinical research, analytical services & sciences, healthcare technologies and medical devices. It provides financing for early and growth stage capital requirements. | Finance |
Videregen Ltd.
Videregen Ltd. BiotechnologyHealth Technology Operates a regenerative medicine company created to address the chronic shortage of organs for transplantation | Health Technology |
Spark Nw Carry Partner LLP | |
Nwf4b Directors Ltd. | |
Dadu Investments Ltd. | |
EnXray Ltd.
EnXray Ltd. Information Technology ServicesTechnology Services Develops sterilization technology solutions for medical device manufacturing companies | Technology Services |
- Stock Market
- Insiders
- Marc d'Abbadie
Choose MarketScreener 
